Empirin and Fatigue - a phase IV clinical study of FDA data

Summary:

No or too few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 25, 2023

No or too few reports are found.

What is Empirin?

Empirin has active ingredients of aspirin. Currently, eHealthMe is studying from 59 Empirin users.

What is Fatigue?

Fatigue (feeling of tiredness) is found to be associated with 5,456 drugs and 6,221 conditions by eHealthMe. Currently, we are studying 905,049 people who have Fatigue.

Do you take Empirin and have Fatigue?

Check whether Fatigue is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Fatigue and when was it recovered:

Fatigue in Empirin

Expand to all the drugs that have ingredients of aspirin:

Fatigue and drugs with ingredients of aspirin (44,227 reports)

Alternative drugs to, pros and cons of Empirin:

Empirin (59 reports)

Browse all side effects of Empirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Fatigue treatments and more:

Fatigue (905,049 reports)

All the drugs that are associated with Fatigue:

Fatigue

All the conditions that are associated with Fatigue:

Fatigue

How the study uses the data?

The study uses data from the FDA. It is based on aspirin (the active ingredients of Empirin) and Empirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.